Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses.
Aluminum hydroxide salts (alum) have been added to inactivated vaccines as safe and effective adjuvants to increase the effectiveness of vaccination. However, the exact cell types and immunological factors that initiate mucosal immune responses to alum adjuvants are unclear. In this study, the mecha...
Enregistré dans:
Auteurs principaux: | Eita Sasaki, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Isao Hamaguchi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/15c234d22ce84c1fafd85299b4e18f64 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Impact of injection buffer volume to perform bronchoalveolar lavage fluid collection for isolating alveolar macrophages to investigate fine particle-induced IL-1α secretion
par: Eita Sasaki, et autres
Publié: (2021) -
Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy
par: Qiuting Chen, et autres
Publié: (2021) -
Neutrophil swarming and extracellular trap formation play a significant role in Alum adjuvant activity
par: J. Stephen, et autres
Publié: (2017) -
An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit Vaccine Is Not Reversible by Sequential Immunization with Nucleic Acid-Adjuvanted Th1-Oriented Subunit Vaccines
par: Han Cao, et autres
Publié: (2021) -
Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
par: Yinyan Yin, et autres
Publié: (2021)